團隊川崎症論文發表(till 2023/12, total : 155 articles)

Year 2005 (SCI: 2)

1.  Chih-Lu Wang, Yu-Tsun Wu, Chieh-An Liu, Ho-Chang Kuo, Kuender D. Yang. Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J. 2005;24:998-1004. (2017, SCI IF:2.305, ranking: 113/155, Q3 in immunology)

Year 2006 (non-SCI: 2)

2.  Ho-Chang Kuo, Yu-Tsun Wu, Kuender D. Yang, Chih-Lu Wang. New concepts and treatment strategy in Kawasaki disease. Acta Paediatr Taiwan. 2006;47(suppl):7-17.

Year 2007 (SCI total 5)

3.  Ho-Chang Kuo, Kuender D. Yang, Chi-Di Liang, Chin-Nam Bong, Hong-Ren Yu, Lin Wang, Chih-Lu Wang. The relationship of eosinophilia to intavenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol. 2007;18:354-359. (2009, SCI IF: 2.676, ranking: 67/128, Q3 in immunology)

4.  Ho-Chang Kuo, Chih-Lu Wang, Chi-Di Liang, Hong-Ren Yu, Hsin-Hsu Chen, Lin Wang, Kuender D. Yang. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect. 2007;40:395-400. (2017, SCI IF: 2.094, ranking: 120/155, Q4 in immunology)

Year 2008 (SCI total 3)

5.  Ho-Chang Kuo, Chih-Lu Wang, Lin Wang, Hong-Ren Yu, Kuender D. Yang. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease. Pediatr Allergy Immunol. 2008;19:184-185. (2009, SCI IF: 2.676, ranking: 67/128, Q3 in immunology)

Year 2009 (total 7; SCI: 6; non-SCI: 1)

6.  Ho-Chang Kuo, Chih-Lu Wang, Chi-Di Liang, Chien-Fu Huang, Hong-Ren Yu, Lin Wang, Kao-Pin Hwang, Kuender D. Yang. The association of lower Eosinophil-related T Helper 2 (Th2) Cytokines with the Coronary Artery Lesions in Kawasaki disease. Pediatr Allergy Immunol 2009;20:266-272. (2009, SCI IF: 2.676, ranking: 67/128, Q3 in immunology)

7.  Hong-Ren Yu, Ho-Chang Kuo, Jiunn-Ming Sheen, Lin Wang, I-Chun Lin, Chih-Lu Wang, Kuender D. Yang. A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease. Pediatr Allergy Immunol. 2009;20:699-707. (2009, SCI IF: 2.676, ranking: 67/128, Q3 in immunology)

8.   Chi-Di Liang, Ho-Chang Kuo, Kuender D. Yang, Chih-Lu Wang, Sheung-Fat Ko . Acquired Coronary Artery Fistula Complicated by Kawasaki disease. American Heart Journal. 2009;157:584-588. (2017, SCI IF: 4.171, ranking: 39/128, Q2 in cardiac & cardiovascular systems)

9.  Ho-Chang Kuo, Chih-Chiang Wu, Tsung-Hsien Yang, Hong-Ren Yu, Chi-Di Liang, Yi-Ju Chen, Kuender D. Yang. Non-Langerhans Cell Histiocytosis in a Child with Kawasaki disease. BMJ Case Reports 2009 [doi:10.1136/bcr.11.2008.1227]

Year 2010 (total 9; SCI: 7, non-SCI: 2)

10.    Yu-Chen Liu, Chiu-Ping Hou, Chiu-Ming Kuo, Chi-Di Liang, *Ho-Chang Kuo. Atypical Kawasaki Disease- Review of Literature and Clinical Nursing. Hu Li Za Zhi. 2010 Dec;57(6):104-110.

11.    Ho-Chang Kuo, Chi-Di Liang, Chih-Lu Wang, Hong-Ren Yu, Kao-Pin Hwang, Kuender D. Yang. Serum Albumin Level Predicts Initial Intravenous Immunoglobulin Treatment Failure in Kawasaki Disease. Acta Paediatr. 2010;99:1578-1583. (2017, SCI IF: 2.58, ranking: 28/124, Q1 in pediatrics)

12.    Hong-Ren Yu, Ho-Chang Kuo, Eng-Yen Huang, Chi-Di Liang, Kao-Pin Hwang, I-Chun Lin, Jiunn-Ming Sheen, Tzu-Jou Wang, Chih-Lu Wang and Kuender D. Yang. Plasma Clusterin Levels in Predicting the Occurrence of Coronary Artery Lesions in Patients With Kawasaki Disease. Pediatr Cardiol. 2010 Nov;31(8):1151-6. (2017, SCI IF: 1.54, ranking: 92/128, Q3 in cardiac & cardiovascular systems)

Year 2011 (total 23; SCI: 22, non-SCI: 1)

13.  Ho-Chang Kuo, Chi-Di Liang, Hong-Ren Yu, Chih-Lu Wang, I-Chun Lin, Chia-An Liu, Jen-Chieh Chang, Chiu-Ping Lee, Wei-Chiao Chang, Kuender D. Yang. CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease. J Clin Immunol. 2011 Apr; 31(2):240-4. (2017, SCI IF: 4.227, ranking: 45/155, Q2 in immunology)

14.   Ho-Chang Kuo, Hong-Ren Yu, Suh-Hang Hank Juo, Kuender D. Yang, Yu-Shiuan Wang, Chi-Di Liang, Wei-Chiao Chen, Wei-Pin Chang, Chien-Fu Huang, Chou-Peen Lee, Li-Yan Lin, Yu-Chen Liu, Yuh-Cherng Guo and Wei-Chiao Chang. CASP3 (rs72689236) gene single nucleotide polymorphisms and Kawasaki disease in Taiwanese children. J Hum Genet. 2011 Feb;56(2):161-5. (2017, SCI IF: 2.942, ranking: 73/171, Q2 in genetics & heredity)

15.  Ho-Chang Kuo, Yu-Chen Liu, Chi-Di Liang, Kuender D. Yang. 兒科十大棘手疾病之首--川崎症. Taiwan Medical Journal 2011;54 (2):69-73.

16.  Ho-Chang Kuo, Kuender D. Yang, Suh-Hang Hank Juo, Chi-Di Liang, Wei-Chiao Chen, Yu-Shiuan Wang, Chih-Hung Lee, Edward His, Hong-Ren Yu, Peng-Yeong Woon, I-Chun Lin, Chien-Fu Huang, Daw-Yang Hwang, Chou-Peen Lee, Li-Yan Lin, Wei-Pin Chang, and Wei-Chiao Chang. ITPKC single nucleotide polymorphism (rs28493229) associated with the susceptibility and coronary artery aneurysm formation in Kawasaki disease patients in a Taiwanese population. PLoS One. 2011 Apr 14;6(4):e17370. (2017, SCI IF: 2.766, ranking: 15/64, Q1 in multidisciplinary sciences)

17.  Ho-Chang Kuo, Ying-Jui Lin, Suh-Hang Hank Juo, Yu-Wen, Hsu, Wei-Chiao Chen, Kuender D. Yang, Chi-Di Liang, Shengyu Yang, Mei-Chyn Chao, Hong-Ren Yu, Shouyan Wang, Li-Yan Lin, and Wei-Chiao Chang. Lack of Association between ORAI1/CRACM1 Gene Polymorphisms and Kawasaki Disease in Taiwanese Children. J Clin Immunol. 2011 Aug;31(4):650-5. (2017, SCI IF: 4.227, ranking: 45/155, Q2 in immunology)

18.  Ho-Chang Kuo, Wei-Chiao Chang. Genetic polymorphisms of Kawasaki disease. Acta Pharmacol Sin. 2011 Oct;32(10):1193-8. (2017, SCI IF: 2.58, ranking: 28/124, Q1 in pediatrics)

19.  Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, Huang YH, Yang YL, Chao MC, Yu HR, Juan YS, Kuo CM, Yang KD, Huang JS and Chang WC. Polymorphisms of Transforming Growth Factor-β Signaling Pathway and Kawasaki Disease in the Taiwanese population. J Hum Genet. 2011 Dec;56(12):840-5. (2017, SCI IF: 2.942, ranking: 73/171, Q2 in genetics & heredity)

20.  Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, Yeung RS, Tan DE, Sim KS, Wang JJ, Wong TY, Pang J, Mitchell P, Cimaz R, Dahdah N, Cheung YF, Huang GY, Yang W, Park IS, Lee JK, Wu JY, Levin M, Burns JC, Burgner D, Kuijpers TW, Hibberd ML; Hong Kong–Shanghai Kawasaki Disease Genetics Consortium, Lau YL, Zhang J, Ma XJ, Liu F, Wu L; Korean Kawasaki Disease Genetics Consortium, Yoo JJ, Hong SJ, Kim KJ, Kim JJ, Park YM, Hong YM, Sohn S, Jang GY, Ha KS, Nam HK, Byeon JH, Yun SW, Han MK, Lee KY, Hwang JY, Rhim JW, Song MS, Lee HD, Kim DS, Lee JM; Taiwan Kawasaki Disease Genetics Consortium, Chang JS, Tsai FJ, Liang CD, Chen MR, Chi H, Chiu NC, Huang FY, Chang LY, Huang LM, Kuo HC, Huang KP, Lee ML, Hwang B, Huang YC, Lee PC; International Kawasaki Disease Genetics Consortium, Odam M, Christiansen FT, Witt C, Goldwater P, Curtis N, Palasanthiran P, Ziegler J, Nissen M, Nourse C, Kuipers IM, Ottenkamp JJ, Geissler J, Biezeveld M, Tacke C, Filippini L, Brogan P, Klein N, Shah V, Dillon M, Booy R, Shingadia D, Bose A, Mukasa T, Tulloh R, Michie C; US Kawasaki Disease Genetics Consortium, Newburger JW, Baker AL, Rowley AH, Shulman ST, Mason W, Takahashi M, Melish ME, Tremoulet AH; Blue Mountains Eye Study, Viswanathan A, Rochtchina E, Attia J, Scott R, Holliday E, Harrap S.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011 Nov 13;43(12):1241-6. (2019, SCI IF: 38.330, ranking:2/171, Q1 in genetics & heredity)     

Year 2012 (SCI :18, non-SCI:3)

21.  Ho-Chang Kuo, Kuender D. Yang, Wei-Chiao Chang, Luo-Ping Ger, Kai-Sheng Hsieh. Kawasaki Disease: An Update on Diagnosis and Treatment. Pediatr Neonatol. 2012 Feb; 53(1):4-11. (2017, SCI IF: 1.232, ranking: 87/124, Q3 in pediatrics)

22.  Ya-Ling Yang, Wei-Pin Chang, Yu-Wen Hsu, Wei-Chiao Chen, Hong-Ren Yu, Chi-Di Liang, Yao-Ting Tsai, Ying-Hsien Huang, , Kuender D Yang, Ho-Chang Kuo* and Wei-Chiao Chang. Lack of association between CLEC5A gene single nucleotide polymorphisms and Kawasaki disease in Taiwanese children. Journal of Biomedicine and Biotechnology. Volume 2012, Article ID 398628, 5 pages doi:10.1155/2012/398628 (corresponding author*) (2014, SCI IF: 3.169, ranking: 41/123, Q2 in Medicine, Research & Experimental)

23.  Ho-Chang Kuo, Mei-Chyn Chao, Yu-Wen Hsu, Ying-Chi Lin, Ying-Hsien Huang, Hong-Ren Yu, Ming-Feng Hou, Chi-Di Liang, Kuender D. Yang, Chih-Lu Wang and Wei-Chiao Chang. CD40 gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. TheScientificWorldJournal 2012;2012:520865. (2010, SCI IF:1.524, ranking: 13/59, Q1 in multidisciplinary sciences)

24.  Hong-Ren Yu, Wei-Pin Chang, Lin Wang, Ying-Jui Lin, Chi-Di Liang, Kuender D. Yang, Chiu-Ming Kuo, Yi-Chuan Huang, Wei-Chiao Chang, and Ho-Chang Kuo*. DC-SIGN (CD209) Promoter –336 A/G (rs4804803) Polymorphism Associated with Susceptibility of Kawasaki disease. Scientific World Journal. 2012;2012:634835 (corresponding*) (2013, SCI IF:1.219, ranking: 16/55, Q2 in multidisciplinary sciences)

25.  Ho-Chang Kuo, Ya-Ling Yang, Jiin-Haur Chuang, Mao-Meng Tiao, Hong-Ren Yu, Li-Tung Huang, Kuender D Yang, Wei-Chiao Chang, Chiu-Ping Lee, Ying-Hsien Huang. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki Disease. J Clin Immunol. 2012 Aug;32(4):746-52. (2017, SCI IF: 4.227, ranking: 45/155, Q2 in immunology)

26.  Yi-Ching Lee, Ho-Chang Kuo, Jeng-Sheng Chang, Luan-Yin Chang, Li-Min Huang, Ming-Ren Chen, Chi-Di Liang, Hsin Chi, Fu-Yuan Huang, Meng-Luen Lee, Yhu-Chering Huang, Betau Hwang, Nan-Chang Chiu, Kao-Pin Huang, Pi-Chang Lee, Li-Ching Chang, Yi-Min Liu, Ying-Ju Chen, Chien-Hsiun Chen, Taiwan Pediatric ID Alliance , Yuan-Tsong Chen, Fuu-Jen Tsai, Jer-Yuarn Wu. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nature Genetics 2012 Mar 25;44(5):522-5. (Co-1st author) (2020, SCI IF: 38.330, ranking:2/171, Q1 in genetics & heredity)

27.  Li-Yan Lin, Tsung-Hsien Yang, Chi-Di Liang, Hong-Ren Yu, Kuender D. Yang, Yi-Chuan Huang, Wei-Chiao Chang, Ho-Chang Kuo*. Comparison of the laboratory data between Kawasaki disease and enterovirus after IVIG treatment. Pediatric Cardiology 2012 Dec;33(8):1269-74. (corresponding author*)  (2017, SCI IF: 1.54, ranking: 92/128, Q3 in cardiac & cardiovascular systems)

28.  Chih-Jen Chen, Fu-Cheng Huang, Mao-Meng Tiao, Ying-Hsien Huang, Li-Yan Lin, Hong-Ren Yu, Kuender D Yang, Yi-Chuan Huang, Chih-Cheng Chen, Wei-Chiao Chang and Ho-Chang Kuo*. Abnormal Gallbladder Sonography is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease. Scientific World Journal. 2012;2012:485758. (corresponding*) (2013, SCI IF:1.219, ranking: 16/55, Q2 in multidisciplinary sciences)

29.  Chia-Hao Chen, Li-Yan Lin, Kuender D. Yang, Kai-Sheng Hsieh, Ho-Chang Kuo*. Kawasaki disease with G6PD deficiency - report of one case and literature review. J Microbiol Immunol Infect. 2014 Jun;47(3):261-3. (corresponding author*)(2017, SCI IF: 2.094, ranking: 120/155, Q4 in immunology)

30.  Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L, Huang SC, Chien SJ, Huang CF, Wang CL, Yu HR, Chen RF, Yang KD. Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis. PLoS One. 2012;7(6):e38635. (2017, SCI IF: 2.766, ranking: 15/64, Q1 in multidisciplinary sciences)

31.  Ho-Chang Kuo and Wei-Chiao Chang. The Genomics and Pharmacogenomics of Kawasaki Disease. J Cell Sci Ther 2012, 3:6. (editorial)

32.  Yu-Chen Liu, Ying-Hsien Huang, Ying-Jui Lin, and Ho-Chang Kuo*. Diagnosis of atypical Kawasaki disease using the new American Heart Association criteria: Reports of 2 cases and a review of the literature. Journal of Medical Sciences. (corresponding author*)

  Year 2013 (SCI: 9; non-SCI: 2)

33.  I-Chun Lin, Jau-Ling Suen, Shau-Ku Huang, Shun-Chen Huang, Hsin-Chun Huang, Ho-Chang Kuo, Chi-Chen Wei, Feng-Shen Wang, Hong-Ren Yu, Kuender D. Yang. Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease. Immunobiology 2013 Feb;218(2):201-12. (2017, SCI IF: 2.873, ranking: 88/155, Q3 in immunology)

34.  Ying-Jui Lin, I-Chun Lin, Hong-Ren Yu, Hsuan-Chang Kuo, Kuender D. Yang, Wei-Chiao Chang, Chi-Di Liang, Shih-Feng Liu, Ho-Chang Kuo*. Tricuspid Regurgitation in Acute Phase of Kawasaki Disease Associated With Intensive Care Unit Admission. Pediatr Cardiol. 2013 Feb;34(2):250-5. (corresponding author*) (2017, SCI IF: 1.54, ranking: 92/128, Q3 in cardiac & cardiovascular systems)

35.  Yu-Wen Hsu, Hsu-Chen Chien, Chi-Cheng Liang, Kuender D. Yang, Wei-Pin Chang, Ho-Chang Kuo*, Wei-Chiao Chang. Stromal Interaction Molecule 1 Polymorphisms are Associated with Coronary Artery Dilation but not with Aneurysm Formation in Patients with Kawasaki Disease. Journal of Experimental and Clinical Medicine. (corresponding author*)

36.  Ho-Chang Kuo, Wei-Chiao Chang, Kuender D Yang, Hong-Ren Yu, Chih-Lu Wang, Shu-Chen Ho, Chun-Yuh Yang. Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study. BMC Pediatrics 2013 Mar 23;13:38. (2017, SCI IF: 2.042, ranking: 48/124, Q2 in pediatrics)

37.  Chiu-Ping Lee , Ying-Hsien Huang , Yu-Wen Hsu , Kuender D. Yang , Hsu-Chen Chien , Hong-Ren Yu , Ya-Ling Yang , Chih-Lu Wang , Wei-Chiao Chang, Ho-Chang Kuo*. TARC/CCL17 Gene Polymorphisms and Expression Associated with Susceptibility and the Formation of Coronary Artery Aneurysms in Kawasaki Disease. Pediatr Res. 2013 Nov;74(5):545-51. (corresponding author*) (2017, SCI IF: 3.123, ranking: 16/124, Q1 in pediatrics)

38.  Ho-Chang Kuo, Yu-Wen Hsu, Chung-Min Wu, Shawn Hsiang-Yin Chen, Kuo-Sheng Hung, Wei-Pin Chang, Kuender D. Yang, Kai-Sheng Hsieh, Wei-Chiao Chen, Yoshihiro Onouchi, and Wei-Chiao Chang. A Replication Study for Association of ITPKC and CASP3 Two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease. PLoS One. 2013 Jul 24;8(7):e69685. (2017, SCI IF: 2.766, ranking: 15/64, Q1 in multidisciplinary sciences)

39.  Deniz Yeter, Richard Deth, Ho-Chang Kuo*. Mercury promotes catecholamines which potentiate mercurial autoimmunity and arterial vasodilation: implications for ITPKC susceptibility in Kawasaki syndrome. Korean Circ J. 2013 Sep;43(9):581-591. (corresponding author*)  (2017, SCI IF: 1.421, ranking: 101/128, Q4 in cardiac & cardiovascular systems)

40.  Wei-Pin Chang, Shyh-JongWu, Wei-Chiao Chang, and Ho-Chang Kuo*. Population-Based Study of the Association between Urbanization and Kawasaki Disease in Taiwan. TheScientificWorldJournal 2013, Article ID 169365. (corresponding author*) (2010, SCI IF:1.524, ranking: 13/59, Q1 in multidisciplinary sciences)

41.  Mei-Chen Ou-Yang, Ho-Chang Kuo, I-Chun Lin, Jiunn-Ming Sheen, Fu-Chen Huang, Chih-Cheng Chen, Ying-Hsien Huang, Ying-Jui Lin, and Hong-Ren Yu. Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease. TheScientific WorldJournal, 2013, Article ID 382523. (co-1st author*) (2010, SCI IF:1.524, ranking: 13/59, Q1 in multidisciplinary sciences)

42.  Chia-Jung Chang, Ho-Chang Kuo, Jong-Keuk Lee, Chiea Chuen Khor, Li-Ching Chang, Yi-Min Liu, Ying-Ju Chen, Young Mi Hong, Gi Young Jang, Martin L. Hibberd, Taco Kuijpers, David Burgner, Michael Levin, Jane Burns, Sonia Davila, International Kawasaki Disease Genetics Consortium, Korean Kawasaki Disease Genetics Consortium, Taiwan Kawasaki Disease Genetics Consortium, Yuan-Tsong Chen, Chien-Hsiun Chen, Jer-Yuarn Wu & Yi-Ching Lee. Replication of GWAS identification of Kawasaki disease susceptibility genes and a functional study affirm a role for BLK in disease susceptibility. PLoS One. 2013 Aug 30;8(8):e72037. (2017, SCI IF: 2.766, ranking: 15/64, Q1 in multidisciplinary sciences)

43.  Peng Yeong Woon, Wei Chiao Chang, Chi-Cheng Liang, Chun Hung Hsu, Sukhontip Klahan, Ying-Hsien Huang, Wei-Pin Chang and Ho-Chang Kuo.* Increased Risk of Atopic Dermatitis in Preschool Children with Kawasaki Disease: A Population-based Study in Taiwan. Evid Based Complement Alternat Med. 2013;2013:605123 (corresponding author*) ((2017, SCI IF: 2.064, ranking: 10/27, Q2 in integrative & complementary medicine)

44.  Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodó X, Uehara R, Burgner D, Bainto E, Pierce D, Tyree M, Cayan D; Kawasaki Disease Global Climate Consortium. Dahdah N, Gibbon M, Scuccimarri R, McCrindle B, Manlhiot C, Jin CJ, Jin LH, Jin ZY, Piao JH, Zhou Y, Jiao F, Huang GY, Salo E, Cimaz R, Di-Filippo S, Lega JC, Aulakh R, Singh S, Suri D, Bar-Meir M, Cimaz R, Nakamura Y, Uehara R, Lee KY, Han JW, Han MK, Hong YM, Jang GY, Kim DS, Lee HD, Lee JK, Park IS, Song MS, Yun SW, Breunis WB, Kuijpers TW, Tacke CE, Lyskina G, Shirniskaya O, Torbyak A, Bregel L, Soldatova T, Subbotin V, Anton J, Prada F, Ricart S, Bou R, Atalay S, Çiftçi E, İnce E, Karbuz A, Özdemir H, Harnden A, Levin M, Mayon-White R, Tulloh R, Michie C, Wright V, Baker AL, Newburger JW, Innocentini N, Shulman S, Anderson M, Dominguez S, Glode M, Arrieta A, Dozal C, Mason W, Beck J, Burns J, Tremoulet A, Fernandez S, Magalhaes CM, Pratesi R, Cheung YF, Reyes M, Advani N, Olugbuyi O, Pierre R, Castaño E, Estripeaut D, Sáez-Llorens X, Chen C, Choo T, Tan T, Wong K, Kuo HC, Lin MT, Wu MH, Sittiwangkul R, Melish M, Burgner D, Odam M, Salgado A, Soza G, Doran J, Heaton P, Wilson N, Eley B, Moore D. Seasonality of Kawasaki disease: a global perspective. PLoS One. 2013 Sep 18;8(9):e74529. doi: 10.1371/journal.pone.0074529. eCollection 2013. (2017, SCI IF: 2.766, ranking: 15/64, Q1 in multidisciplinary sciences)

 

Year 2014  (SCI 12, non SCI 2)

45.  Kuo HC, Hsu YW, Lo MH, Huang YH, Chien SC, Chang WC. Single-Nucleotide Polymorphism rs7251246 in ITPKC Is Associated with Susceptibility and Coronary Artery Lesions in Kawasaki Disease. PLoS One. 2014 Mar 12;9(3):e91118. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用23次。

46.  Ho-Chang Kuo, Chung-Min Wu, Wei-Pin Chang, Chun-Nan Kuo, Deniz Yeter, Chun-Yi Lin, Jei-Tsung Pai, Ying-Chen Chi, Chia-Hsien Lin, Liang-Jen Wang and Wei-Chiao Chang. Association between Kawasaki Disease and Autism: A Population-Based Study in Taiwan. Int. J. Environ. Res. Public Health. 2014 11(4), 3705-3716. (2018, SCI IF:2.468, ranking: 112/250, Q2 in ENVIRONMENTAL SCIENCES),被引用8次。

47.  Wu TH, Kuo HC, Tain YL, Lin KM, Kuo HC, Chien SJ. Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease. BMC Pediatr. 2014 Apr 10;14(1):98. (2018, SCI IF:1.983, ranking: 56/124, Q2 in PEDIATRICS),被引用12次。

48.  Huang YH, Tain YL, Lee CP, Kuo HC*. Asymmetric and Symmetric Dimethylarginine Are Associated with Coronary Artery Lesions in Kawasaki Disease. J Pediatr. 2014 Aug;165(2):295-9.. (corresponding author*) (2008, 4.122, ranking: 4/86, Q1 in Pediatrics),被引用2次。

49.  Wan-Ning Tseng, Mao-Hung Lo, Kai-Sheng Hsieh, Wei-Chiao Chang, Ho-Chang Kuo*. IL-31 associated with coronary artery lesion formation in Kawasaki disease. PLoS One. 2014 Aug 14;9(8):e105195. PLoS One. 2013 Aug 30;8(8):e72037. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用15次。

50.  Ho-Chang Kuo, Ying-Hsien Huang, Shu-Chen Chien, Hong-Ren Yu, Kai-Sheng Hsieh, Yu-Wen Hsu, and Wei-Chiao Chang. Genetic variants of CD209 associated with Kawasaki disease susceptibility. PLoS One. 2014 Aug 22;9(8):e105236. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用7次。

51.  Sandi C Lin, Wan-Lin Tseng, Mindy Ming-Huey Guo and Ho-Chang Kuo*. Etanercept as Rescue Therapy for Refractory Kawasaki Disease. Austin J Pediatr. 2014;1(2):1010. (corresponding author*)

52.   Kuo HC*, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD. Identification of an Association Between Genomic Hypomethylation of FCGR2A and Susceptibility to Kawasaki Disease and Intravenous Immunoglobulin Resistance by DNA Methylation Array. Arthritis Rheumatol. 2015 Mar;67(3):828-36. (2018, SCI IF:9.002, ranking: 3/31, Q1 in RHEUMATOLOGY),被引用40次。

53.  Mindy Ming-Huey Guo, Wan-Ning Tseng, Chia-Hung Ko, Hui-Mei Pan, Kai-Sheng Hsieh, Ho-Chang Kuo*. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 2015 Mar;70(3):310-8. (2018, SCI IF:6.771, ranking: 25/158, Q1 in IMMUNOLOGY),被引用67次。

54.  Ko TM, Kuo HC, Chang JS, Chen SP, Liu YM, Chen HW, Tsai FJ, Lee YC, Chen CH, Wu JY, Chen YT. CXCL10/IP-10 is a Biomarker and Mediator for Kawasaki Disease. Circ Res. 2015 Feb 27;116(5):876-83. (co-1st author) (2018, SCI IF:15.862, ranking: 5/136, Q1 in CARDIAC & CARDIOVASCULAR SYSTEM),被引用51次。

55.  Kuo HC, Hsu YW, Wu MS, Woon PY, Wong HS, Tsai LJ, Lin RK, Klahan S, Hsieh KS, Chang WC. FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. Mediators Inflamm. 2015;2015:564625. (2018, SCI IF:3.545, ranking: 93/193, Q2 in CELL BIOLOGY),被引用14次。

56.  Kuo HC, Chang WC, Wang LJ, Li SC, Chang WP. Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study. Epidemiol Psychiatr Sci. 2015 Sep 22:1-8. (2018, SCI IF:6.402, ranking: 13/146, Q1 in PSYCHIATRY),被引用2次。

57.  Ho-Chang Kuo*, Jen-Chieh Chang, Mindy Ming-Huey Guo, Kai-Sheng Hsieh, Deniz Yeter, Sung-Chou Li, Kuender D. Yang. Gene-gene associations with the susceptibility of Kawasaki disease and coronary artery lesions. PLoS One. 2015 Nov 30;10(11):e0143056. (1st and correspondence author) (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用14次。

58.  Kuo H-C, Lo M-H, Hsieh K-S, Guo MM-H, Huang Y-H. High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease. PLoS ONE 2015, 10(12): e0144603. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用50次。

Year 2016 (SCI 18)

59.  Yeter D, Portman MA, Aschner M, Farina M, Chan WC, Hsieh KS, Kuo HC.* Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children. Int J Environ Res Public Health. 2016 Jan 5;13(1). (2018, SCI IF:2.468, ranking: 112/251, Q2 in ENVIRONMENTAL SCIENCES),被引用11次。

60.  Tseng HC, Ho JC, Guo MM, Lo MH, Hsieh KS, Tsai WC, Kuo HC*, Lee CH. Bull's eye dermatoscopy pattern at bacillus Calmette-Guérin inoculation site correlates with systemic involvements in patients with Kawasaki disease. J Dermatol. 2016 Sep;43(9):1044-50. (2018, SCI IF:3.377, ranking: 14/66, Q1 in DERMATOLOGY),被引用10次。

61.  Kuo HC, Hsu YW, Wu MS, Chien SC, Liu SF, Chang WC. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease. J Microbiol Immunol Infect. 2016 Feb;49(1):1-7. (invited review article) (2018, SCI IF:2.455, ranking: 115/158, Q3 in IMMUNOLOGY),被引用32次。

62.  Huang YH, Hsu YW, Lu HF, Wong HS, Yu HR, Kuo HC, Huang FC, Chang WC, Kuo HC*. Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease. Medicine (Baltimore). 2016 Apr;95(17):e3501. (corresponding author). (2018, SCI IF:1.870, ranking: 69/160, Q2 in MEDICINE, GENERAL & INTERNAL),被引用15次。

63.  Huang YH, Kuo HC, Huang FC, Yu HR, Hsieh KS, Yang YL, Sheen JM, Li SC, Kuo HC*. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. Int J Mol Sci. 2016 May 12;17(5). (corresponding author) (2018, SCI IF:4.183, ranking: 46/172, Q2 in CHEMISTRY, MULTIDISCIPLINARY),被引用21次。

64.  Kuo HC, Li SC, Guo MM, Huang YH, Yu HR, Huang FC, Jiao F, Kuo HC, Andrade J, Chan WC. Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. PLoS One. 2016 May 12;11(5):e0154943. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用34次。

65.  Ho-Chang Kuo, Kai-Sheng Hsieh, Mindy Ming-Huey Guo, Ken-Pen Weng, Luo-Ping Ger, Wen-Ching Chan, Sung-Chou Li. Next-generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease. Journal of Allergy and Clinical Immunology. 2016 Oct;138(4):1227-1230. (2018, SCI IF:14.110, ranking: 6/158, Q1 in IMMUNOLOGY),被引用18次。

66.  Li SC, Chan WC, Huang YH, Guo MM, Yu HR, Huang FC, Kuo HC, Kuo HC*. Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease. BMC Med Genomics. 2016 Aug 12;9 Suppl 1:37. (SCI IF: 3.13) (corresponding author). (2018, SCI IF:2.568, ranking: 91/174, Q3 in GENETICS & HEREDITY),被引用16次。

67.  Kuo HC, Wang CL, Yang KD, Lo MH, Hsieh KS, Li SC, Huang YH. Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease. PLoS One. 2016 Aug 15;11(8):e0161265. (2018, SCI IF:2.776, ranking: 24/69, Q2 in MULTIDISCIPLINARY SCIENCES),被引用15次。

68.  Hong-Ren Yu, Ying-Hsien Huang, Hsing-Chun Kuo, Fu-Chen Huang, Hsin-Chun Huang, Sung-Chou Li, Kai-Sheng Hsieh, Ho-Chang Kuo*. Distinct expressions of immunoglobulin signal related molecules between human Kawasaki disease and BALB/c mice treated with Lactobacillus asei cell wall extract. Int J Clin Exp Med. 2016;9(10):19502-19511. (corresponding author) (2018, SCI IF:0.181, ranking: 135/136, Q4 in MEDICINE, RESEARCH & EXPERIMENTAL)

Year 2017

69.  Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC*. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease. Oncotarget. 2017 Jan 10;8(2):2044-2052. (corresponding author) (2016, SCI IF: 5.168, ranking: 48/190, Q2 in cell biology),被引用6次。

70.  Huang YH, Li SC, Huang LH, Chen PC, Lin YY, Lin CC, Kuo HC*. Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease. Oncotarget. 2017 Feb 14;8(7):11249-11258. (corresponding author) (2016, SCI IF: 5.168, ranking: 48/190, Q2 in cell biology),被引用24次。

71.  Huang FC, Kuo HC, Huang YH, Yu HR, Li SC, Kuo HC. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. BMC Pharmacol Toxicol. 2017 Jan 9;18(1):3. (2018, SCI IF:2.103, ranking: 66/93, Q3 in TOXICOLOGY),被引用18次。

72.  Huang YH, Kuo HC*. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int J Mol Sci. 2017 Apr 12;18(4). (invited review, corresponding author) (2018, SCI IF:4.183, ranking: 46/172, Q2 in CHEMISTRY, MULTIDISCIPLINARY),被引用11次。

73.  Huang YH, Yang KD, Hsu YW, Lu HF, Wong HS, Yu HR, Kuo HC, Huang FC, Lo MH, Hsieh KS, Chen SF, Chang WC, Kuo HC*. Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease. Oncotarget. 2017 May 8;8(31):51859-51868. (corresponding author) (2016, SCI IF: 5.168, ranking: 48/190, Q2 in cell biology),被引用7次。

74.  Kuo HC.* Preventing coronary artery lesions in Kawasaki disease. Biomed J. 2017 Jun;40(3):141-146. (invited review) (2018, SCI IF:2.301, ranking: 198/299, Q3 in BIOCHEMISTRY & MOLECULAR BIOLOGY),被引用19次。

75.  Chang LS, Hsu YW, Lu CC, Lo MH, Hsieh KS, Li SC, Chang WC, Kuo HC*. CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease. Pediatr Infect Dis J. 2017 Nov;36(11):1039-1043. (2018, SCI IF:2.317, ranking: 120/158, Q4 in IMMUNOLOGY),被引用8次。

76.  Liang-Jen Wang, Ho-Chang Kuo*. Cognitive Development After Kawasaki Disease- Clinical Study and Validation Using a Nationwide Population-Based Cohort. Circ J. 2017 Sep 9. doi: 10.1253/circj.CJ-17-0557. (2018, SCI IF:3.025, ranking: 55/136, Q2 in CARDIAC & CARDIOVASCULAR SYSTEM),被引用3次。

77.  Kuo HC, Wong HS, Chang WP, Chen BK, Wu MS, Yang KD, Hsieh KS, Hsu YW, Liu SF, Liu X, Chang WC. Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease. Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001625. (2018, SCI IF:4.897, ranking: 33/136, Q1 in CARDIAC & CARDIOVASCULAR SYSTEM),被引用13次。

78.  Kuo HC, Li SC, Huang LH, Huang YH. Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease. Oncotarget. 2017 Jul 28;8(37):60875-60891. (2016, SCI IF: 5.168, ranking: 48/190, Q2 in CELL BIOLOGY),被引用9次。

Year 2018

79.  Kuo HC, Huang YH, Chung FH, Chen PC, Sung TC, Chen YW, Hsieh KS, Chen CS, Syu GD. Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays. Mol Cell Proteomics. 2018 Mar;17(3):472-481. (2018, SCI IF:4.828, ranking:7/79, Q1 in BIOCHEMICAL RESEARCH METHODS),被引用4次。

80.  Huang YH, Kuo HC, Li SC, Cai XY, Liu SF, Kuo HC*. HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease. J Mol Cell Cardiol. 2018 Mar 2;117:82-87. (corresponding author) (2018, SCI IF:5.055, ranking: 52/193, Q2 in CELL BIOLOGY),被引用10次。

81.  Huang YH, Lo MH, Cai XY, Kuo HC*. Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease. Oncotarget. 2018 Apr 10;9(27):18939-18948. (corresponding author) (2016, SCI IF: 5.168, ranking: 48/190, Q2 in cell biology),被引用6次。

82.  Kuo HC, Lo CC, Lin PX, Kao CC, Huang YH, Lin BS. Wireless optical monitoring system identifies limb induration characteristics in patients with Kawasaki disease. J Allergy Clin Immunol. 2018 May 4. pii: S0091-6749(18)30631-6. (2018, SCI IF:14.110, ranking: 6/158, Q1 in IMMUNOLOGY) 被引用1次。

83.  Kuo HC*, Guo MM, Lo MH, Hsieh KS, Huang YH. Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial. BMC Pediatr. 2018 Jun 22;18(1):200. doi: 10.1186/s12887-018-1180-1. (2018, SCI IF:1.983, ranking: 56/125, Q2 in PEDIATRICS),被引用11次。

84.  Chen KD, Huang YH, Ming-Huey Guo M, Lin TY, Weng WT, Yang HJ, Yang KD, Kuo HC*. The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease. Oncotarget. 2018 Jun 19;9(47):28337-28350. (2016, SCI IF: 5.168, ranking: 48/190, Q2 in cell biology),被引用3次。

85.  Huang LH, Kuo HC, Pan CT, Lin YS, Huang YH, Li SC.  Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration. Clin Epigenetics. 2018 Nov 1;10(1):135. doi: 10.1186/s13148-018-0557-1. (co-1st author, SCI IF: 6.09) (2018, SCI IF:5.496, ranking: 43/230, Q1 in ONCOLOGY),被引用8次。

Year 2019

86.  Huang YH, Chen KD, Lo MH, Cai XY, Kuo HC.* Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment. Front Pediatr. 2019 Feb 4;7:7. (corresponding author) (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

87.  Huang YH, Lo MH, Cai XY, Liu SF, Kuo HC.* Increase expression of CD177 in Kawasaki disease. Pediatr Rheumatol Online J. 2019 Apr 3;17(1):13. (2020, SCI IF:3.054, ranking: 34/129, Q2 in PEDIATRICS)

88.  Huang YH, Lin KM, Ho SC, Yan JH, Lo MH, Kuo HC. Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study. Front Pediatr. 2019 Mar 29;7:121. (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

89.  Huang YH, Chen KD, Lo MH, Cai XY, Chang LS, Kuo YH, Huang WD, Kuo HC*. Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease. Int J Med Sci. 2019 Apr 25;16(4):576-582. (2020, SCI IF:3.738, ranking: 44/167, Q1 in MEDICINE, GENERAL & INTERNAL)

90.  Kuo HC, Pan CT, Huang YH, Huang FC, Lin YS, Li SC, Huang LH. Global Investigation of Immune Repertoire Suggests Kawasaki Disease Has Infectious Cause. Circ J. 2019 Sep 25;83(10):2070-2078. (2020, SCI IF: 2.993, ranking: 74/142, Q3 in CARDIAC & CARDIOVASCULAR SYSTEM)

91.  Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.* Association between maternal age and outcomes in Kawasaki disease patients. Pediatr Rheumatol Online J. 2019 Jul 19;17(1):46. (2020, SCI IF:3.054, ranking: 34/129, Q2 in PEDIATRICS)

92.  Chang LS, Ming-Huey Guo M, Lo MH, Kuo HC*. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease. Pediatr Res. 2019 Dec 9. doi: 10.1038/s41390-019-0707-y. (2020, SCI IF:3.756, ranking:17/129, Q1 in PEDIATRICS)

Year 2020

93.  Chang LS, Kuo HC*. The role of corticosteroids in the treatment of Kawasaki disease. Expert Rev Anti Infect Ther. 2020 Feb;18(2):155-164. (2020, SCI IF:5.091, ranking: 156/357, Q2 in PHARMACOLOGY & PHARMACY)

94.  Chang SF, Liu SF, Chen CN, Kuo HC*. Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro. Cell Biosci. 2020 Mar 11;10:36. doi: 10.1186/s13578-020-00400-8. eCollection 2020. (2020, SCI IF: 7.151, Q1 in BIOLOGY)

95.  Chang LS, Guo MM, Yan JH, Huang YH, Lo MH, Kuo HC*. Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset. Pediatr Allergy Immunol. 2020 Feb 19. doi: 10.1111/pai.13235. (2020, SCI IF: 6.377, ranking 7/28, Q1 in ALLERGY)

96.  Yan JH, Chang LS, Lin YJ, Guo MM, Huang YH, Kuo HC*. Clinical Characteristics for Differentiating Febrile Children With Suspected Kawasaki Disease Diagnosis. Front Pediatr. 2020 May 5;8:221. doi: 10.3389/fped.2020.00221. eCollection 2020. (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

97.  Tai IH, Wu PL, Guo MM, Lee J, Chu CH, Hsieh KS, Kuo HC*. Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease. BMC Pediatr. 2020 May 11;20(1):203. doi: 10.1186/s12887-020-02111-y. (2020, SCI IF:2.125, ranking: 70/129, Q3 in PEDIATRICS)

98.  Guo MM, Chang LS, Huang YH, Wang FS, Kuo HC*. Epigenetic Regulation of Macrophage Marker Expression Profiles in Kawasaki Disease. Front Pediatr. 2020 Apr 3;8:129. doi: 10.3389/fped.2020.00129. eCollection 2020. (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

99.  Chang LS, Yan JH, Li JY, Yeter DD, Huang YH, Guo MM, Lo MH, Kuo HC*. Blood Mercury Levels in Children with Kawasaki Disease and Disease Outcome. Int J Environ Res Public Health. 2020 May 25;17(10):E3726. 2020, SCI IF:3.390, ranking: 81/306, Q2 in ENVIRONMENTAL SCIENCES)

100.  Chang LS, Lin YJ, Yan JH, Guo MM, Lo MH, Kuo HC*. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease. BMC Pediatr. 2020 Aug 24;20(1):398. (2020, SCI IF:2.125, ranking: 70/129, Q3 in PEDIATRICS)

101.  Kuo HC*. Kawasaki-like disease among Italian children in the COVID-19 era. J Pediatr. 2020 Sep;224:179-183. (invited Commentary) (2020, SCI IF: 4.406, ranking 11/129, Q1 in Pediatrics)

102.  Liu XP, Huang YS, Kuo HC, Xia HB, Yi-Sun, Huang WD, Lang XL, Liu CY, Liu X. A novel nomogram model for differentiating Kawasaki disease from sepsis. Sci Rep. 2020 Aug 13;10(1):13745. (Co-first author) (2020, SCI IF:4.380, ranking: 18/128, Q1 in MULTIDISCIPLINARY SCIENCES)

103.  Hsu YW, Lu HF, Chou WH, Kuo HC*, Chang WC. Functional Correlations between CXCL10/IP10 Gene Polymorphisms and Risk of Kawasaki Disease. Pediatr Allergy Immunol. 2020 Sep 29. doi: 10.1111/pai.13381. (2020, SCI IF: 6.377, ranking 5/129, Q1 in PEDIATRICS) (correspondence author)

104.  林怡攸(Yi-Yu Lin) 黃巧菱(Chiao-Lin Huang) 鄭家榛(Chia-Chen Cheng) 王敏惠(Min-Hui Wang) 林瓊君(Chiung-Chun Lin) 邱燕甘(Yen-Gan Chiou) 郭和昌(Ho-Chang Kuo) 川崎症住院病童友善醫療照護流程之改善專案 (Friendly Health Care Improvement Program for Hospitalized Children with Kawasaki Disease) 健康科技期刊;71 (2020 / 09 / 01) P12 - 23. 繁體中文 DOI 10.6979/TJHS.202009_7(1).0002.

105.  Huang FC, Huang YH, Kuo HC, Li SC. Identifying Downregulation of Autophagy Markers in Kawasaki Disease. Children (Basel). 2020 Oct 4;7(10):E166. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS)

106.  Yang TH, Lee YY, Wang LY, Chang TC, Chang LS, Kuo HC*. Patients with Kawasaki Disease Have Significantly Low Aerobic Metabolism Capacity and Peak Exercise Load Capacity during Adolescence. Int J Environ Res Public Health. 2020 Nov 11;17(22):E8352. (correspondence author) (2020, SCI IF:3.390, ranking: 81/306, Q2 in ENVIRONMENTAL SCIENCES)

107.  Kuo KC, Yang YL, Lo MH, Cai XY, Kuo HC*, Huang YH. The Expression of Glycoprotein Genes in the Inflammatory Process of Kawasaki Disease. Front Pediatr. 2020 Dec 3;8:592122. (correspondence author) (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

108.  Tsai CM, Yu HR, Tang KS, Huang YH, Kuo HC*, C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease. Front Pediatr. 2020 Nov 25;8:607631. (correspondence author) (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

109.  Liu XP, Huang YS, Xia HB, Sun Y, Lang XL, Li QZ, Liu CY, Kuo HC*, Huang WD, Liu X. A Nomogram Model Identifies Eosinophilic Frequencies to Powerfully Discriminate Kawasaki Disease From Febrile Infections. Front Pediatr. 2020 Dec 11;8:559389. doi: 10.3389/fped.2020.559389. eCollection 2020. (First + Corresponding author) (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

Year 2021

110.  Huang PY, Huang YH, Guo MM, Chang LS, Kuo HC.* Kawasaki Disease and Allergic Diseases.  Front Pediatr. 2021 Jan 7;8:614386. doi: 10.3389/fped.2020.614386. eCollection 2020. (correspondence author) (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

111.  Tsai CM, Chu CH, Liu X, Weng KP, Liu SF, Huang YH, Kuo HC.* A novel score system of blood tests for differentiating Kawasaki disease from febrile children. PLoS One. 2021 Jan 22;16(1):e0244721. doi: 10.1371/journal.pone.0244721. eCollection 2021. (correspondence author) (2020, SCI IF:3.240, ranking: 26/72, Q2 in MULTIDISCIPLINARY SCIENCES)

112.  Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children. Front Immunol. 2021 Feb 26;12:632890. (2020, SCI IF:7.561, ranking: 24/162, Q1 in IMMUNOLOGY) (co-1st author)

113.  Chen KD, Lin WC, Kuo HC*. Chemical and Biochemical Aspects of Molecular Hydrogen in Treating Kawasaki Disease and COVID-19. Chem Res Toxicol. 2021 Mar 15. doi: 10.1021/acs.chemrestox.0c00456. (2020, SCI IF:3.739, ranking: 38/93, Q2 in TOXICOLOGY) (1st + Corresponding author)

114.  Yu HJ, Chuang MN, Chu CL, Wu PL, Ho SC, Kuo HC.* Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia. J Clin Med. 2021 Mar 30;10(7):1381. (2020, SCI IF:4.242, ranking: 39/167, Q1 in MEDICINE, GENERAL & INTERNAL) (Corresponding author)

115.  Lai WT, Lee HC, Huang YH, Lo MH, Kuo HC.* Tight junction protein ZO-1 in Kawasaki disease. BMC Pediatr. 2021 Mar 31;21(1):157. (2020, SCI IF:2.125, ranking: 70/129, Q3 in PEDIATRICS) (Corresponding author)

116.  Chang LS, Weng KP, Yan JH, Lo WS, Guo MM, Huang YH, Kuo HC.* Desquamation in Kawasaki Disease. Children (Basel). 2021 Apr 21;8(5):317. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS) (Corresponding author)

117.  Chang LS, Ming-Huey Guo M, Lo MH, Kuo HC*. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease. Pediatr Res. 2021 Jan;89(1):191-197. (2020, SCI IF:3.756, ranking:17/129, Q1 in PEDIATRICS)

118.   Chang LS, Yu HR, Chu CL, Chen KD, Huang YH, Guo MM, Weng KP, Kuo HC.* Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease. J Clin Med. 2021 May 27;10(11):2347. (2020, SCI IF:4.242, ranking: 39/167, Q1 in MEDICINE, GENERAL & INTERNAL) (Corresponding author)

119.  Wang LJ, Tsai ZY, Chang LS, Kuo HC.* Cognitive development of children with Kawasaki disease and the parenting stress of their caregivers in Taiwan: a case-control study. BMJ Open. 2021 Jun 3;11(6):e042996. (2020, SCI IF:2.692, ranking: 64/167, Q2 in MEDICINE, GENERAL & INTERNAL) (Corresponding author)

120.  Tai IH, Hsieh KS, Liao CC, Kuo HC.* Regression of Giant Coronary Aneurysm Validated by Echocardiography in Kawasaki Disease. Circ Cardiovasc Imaging. 2021 Jun 4: CIRCIMAGING120012153. (2020, SCI IF:7.792, ranking: 9/133, Q1 in RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING) (Corresponding author)

121.  Chang LS, Chen YJ, Huang PY, Chen KD, Lo MH, Huang YH, Guo MM, Kuo HC*. Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions. J Am Heart Assoc. 2021 Jun 15;10(12):e020505. (2020, SCI IF:5.501, ranking: 35/142, Q1 in CARDIAC & CARDIOVASCULAR SYSTEMS) (Corresponding author)

122.  Weng KP, Li SC, Chien KJ, Tsai KW, Kuo HC, Hsieh KS, Huang SH. Prediction Model for Diagnosis of Kawasaki Disease Using iTRAQ-Based Analysis.  Children (Basel). 2021 Jul 5;8(7):576. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS)

123.  Yang YL, Kuo HC.* Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan. Children (Basel). 2021 Jul 23;8(8):623. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS) (Corresponding author)

124.  Huang YH, Hsin YC, Wang LJ, Feng WL, Guo MM, Chang LS, Tu YK, Kuo HC.* Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin. Front Pharmacol. 2021 Aug 12;12:725126. doi: 10.3389/fphar.2021.725126. eCollection 2021. (2020, SCI IF:5.811, ranking: 40/276, Q1 in PHARMACOLOGY & PHARMACY) (Corresponding author)

125.  Lee ZM, Chu CL, Chu CH, Chang LS, Kuo HC.* Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease. Pediatr Neonatol. 2021 Oct 12:S1875-9572(21)00180-7. (2020, SCI IF:2.083, ranking: 71/129, Q3 in PEDIATRICS) (Corresponding author)

126.  Huang HC, Kuo HC, Yu HR, Huang HC, Chang JC, Lin IC, Chen IL. Profile of Urinary Cytokines in Kawasaki Disease: Non-Invasive Markers. Diagnostics (Basel). 2021 Oct 8;11(10):1857. (2020, SCI IF:3.706, ranking: 51/315, Q2 in MEDICINE, GENERAL & INTERNAL)

127.  Huang YS, Liu XP, Xia HB, Cui LN, Lang XL, Liu CY, Huang WD, Zhang JY, Liu X, Kuo HC*, Zhou T. Complement 3 and the Prognostic Nutritional Index Distinguish Kawasaki Disease from Other Fever Illness with a Nomogram. Children (Basel). 2021 Sep 20;8(9):825. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS) (Corresponding author)

128.  Kuo KC, Yang YL, Lo MH, Cai XY, Guo MM, Kuo HC*, Huang YH. Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease. Diagnostics (Basel). 2021 Nov 3;11(11):2035. (2020, SCI IF:3.706, ranking: 51/315, Q2 in MEDICINE, GENERAL & INTERNAL) (Corresponding author)

129.  Lei WT, Hsu CW, Chen PC, Tseng PT, Kuo HC, Guo MM, Tu YK, Lin PY, Kao YH, Chang LS. Increased Risk of Asthma and Allergic Rhinitis in Patients With a Past History of Kawasaki Disease: A Systematic Review and Meta-Analyses. Front Pediatr. 2021 Dec 20;9:746856. (2020, SCI IF:3.418, ranking: 24/129, Q1 in PEDIATRICS)

Year 2022

130.  Guo MM, Huang YH, Wang FS, Chang LS, Chen KD, Kuo HC.* CD36 is Associated With the Development of Coronary Artery Lesions in Patients With Kawasaki Disease. Front Immunol. 2022 Jan 27;13:790095. (2020, SCI IF:7.561, ranking: 24/162, Q1 in IMMUNOLOGY) (Corresponding author)

131.  Huang YH, Chen KD, Kuo KC, Guo MM, Chang LS, Yang YL, Kuo HC.* Human Transcriptome Array Analysis Identifies CDR2 as a Novel Suppressed Gene for Kawasaki Disease. Diagnostics (Basel). 2022 Jan 19;12(2):240. (2020, SCI IF:3.706, ranking: 51/315, Q2 in MEDICINE, GENERAL & INTERNAL) (Corresponding author)

132.  Guo MM, Yang KD, Liu SF, Kuo HC.* Number of Kawasaki Disease Admissions Is Associated with Number of Domestic COVID-19 and Severe Enterovirus Case Numbers in Taiwan. Children (Basel). 2022 Jan 24;9(2):149. (2020, SCI IF:2.863, ranking: 40/129, Q2 in PEDIATRICS) (Corresponding author)

133.  Kuo HC, Liu SF, Lin PX, Yang KD, Lin BS. Near Infrared Spectroscopy Detects Change of Tissue Hemoglobin and Water Levels in Kawasaki Disease and Coronary Artery Lesions. Children (Basel). 2022 Feb 22;9(3):299. (SCI IF: 2.863)

134.   Wu WS, Yang TH, Chen KD, Lin PH, Chen GR, Kuo HC.* KDmarkers: A biomarker database for investigating epigenetic methylation and gene expression levels in Kawasaki disease. Comput Struct Biotechnol J. 2022 Mar 10;20:1295-1305. (SCI IF: 7.271)(Corresponding author)

135.  Lo MH, Lin YJ, Kuo HC, Wu YH, Li TY, Kuo HC,* Lin IC. Assessment of vascular and endothelial function in Kawasaki disease. Biomed J. 2022 Mar 28:S2319-4170(22)00045-2. (Corresponding author)

136.  Chen YJ, Guo MM, Chang LS, Kuo HC.* The Impact of Onset Age on Eosinophils in Kawasaki Disease. Biomedicines. 2022 Apr 1;10(4):835. (Corresponding author)

137.  Kuo HC*. Editorial: Genetic and Immunologic Response in Kawasaki Disease. Front Pediatr. 2022 Apr 12;10:876979. (2021, SCI IF:3.569, ranking: 38/130, Q2 in PEDIATRICS) (single author)

138.  Lao S, Zhou T, Kuo HC, Zhong G, Zeng W. Risk Factors for Coronary Artery Lesionsin Kawasaki Disease Independent of Antibiotic Use in Chinese Children. Front Public Health. 2022 May 5;10:817613. (2021, SCI IF:6.461, ranking: 18/182 Q1 in PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH) (Co-1st author)

139.  Liu XP, Huang YH, Tsai YC, Liu SF, Kuo HC.* Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19. Children (Basel). 2022 Apr 28;9(5):638. (2021, SCI IF:2.835, ranking: 59/130, Q2 in PEDIATRICS),被引用2次。(Corresponding author)

140.  Kuo HC.* Hydrogen Gas Inhalation Regressed Coronary Artery Aneurysm in Kawasaki Disease-Case Report and Article Review. Front Cardiovasc Med. 2022 May 12;9:895627. (2021, SCI IF:5.846, ranking: 60/207 Q2 in CARDIAC & CARDIOVASCULAR SYSTEMS) (single author)

141.  Yang YL, Kuo HC, Chen KD, Chu CH, Kuo KC, Guo MM, Chang LS, Huang YH. Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease. Children (Basel). 2022 Jun 18;9(6):913. (2021, SCI IF:2.835, ranking: 59/130, Q2 in PEDIATRICS)

142.  Chang LS, Chen KD, Huang YH, Kuo HC.* Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease. Int J Mol Sci. 2022 Sep 3;23(17):10093. (Corresponding author) (2021, SCI IF:6.208, ranking: 69/296, Q1 in BIOCHEMISTRY & MOLECULAR BIOLOGY)

143.  Chen KD, Huang YH, Wu WS, Chang LS, Chu CL, Kuo HC*. Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19. Front Immunol. 2022 Sep 8;13:995886. (2021, SCI IF:8.786, ranking: 33/161, Q1 in IMMUNOLOGY) (Corresponding author)

144.  Kuo HC, Hao S, Jin B, Chou CJ, Han Z, Chang LS, Huang YH, Hwa K, Whitin JC, Sylvester KG, Reddy CD, Chubb H, Ceresnak SR, Kanegaye JT, Tremoulet AH, Burns JC, McElhinney D, Cohen HJ, Ling XB. Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan. Front Immunol. 2022 Oct 3;13:1031387. (2021, SCI IF:8.786, ranking: 33/161, Q1 in IMMUNOLOGY)

145.  Tai IH, Hsieh KS, Kuo HC.* Beaded Coronary Aneurysm in Kawasaki Disease. Children (Basel). 2022 Sep 24;9(10):1463. (2021, SCI IF:2.835, ranking: 59/130, Q2 in PEDIATRICS) (first + Corresponding author)

146.  Kuo HC, Chen SH, Chen YH, Lin YC, Chang CY, Wu YC, Wang TD, Chang LS, Tai IH, Hsieh KS. Detection of coronary lesions in Kawasaki disease by Scaled-YOLOv4 with HarDNet backbone. Front Cardiovasc Med. 2023 Jan 20;9:1000374.

147.  Tsai CM, Lin CR, Kuo HC, Cheng FJ, Yu HR, Hung TC, Hung CS, Huang CM, Chu YC, Huang YH.  Use of Machine Learning to Differentiate Children With Kawasaki Disease From Other Febrile Children in a Pediatric Emergency Department. JAMA Netw Open. 2023 Apr 3;6(4):e237489. (SCI IF: 13.37)

148.  Chiang WN, Huang PY, Kuo HC, Huang YH, Chang LS. Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis. Front Cardiovasc Med. 2023 Jun 12;10:1164530.

149.  Guo MM, Kuo HC*. The state of play in tools for predicting immunoglobulin resistance in Kawasaki disease. Expert Rev Clin Immunol. 2023 Jul 19:1-7.

150.  Chang LS, Huang YH, Chang HY, Lee ZM, Feng WL, Kuo HC.* Basophils Predict Mite Sensitization in Patients with Kawasaki Disease. Children (Basel). 2023 Jul 12;10(7):1209.

151.  Shyu TC, Wu CJ, Fu YC, Peng YC, Chuang TY, Kuo HC, Hsieh KS, Tai IH. Prevalence of antecedent Kawasaki disease in young adults with suspected acute coronary syndrome in high incidence cohort. Front Cardiovasc Med. 2023 Aug 4;10:1167771.

152.  Keskin BB, Liu SF, Du PX, Tsai PS, Ho TS, Su WY, Lin PC, Shih HC, Weng KP, Yang KD, Huang YH, Kuo KC, Syu GD, Kuo HC*. Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Analyst. 2023 Aug 23. doi: 10.1039/d3an00802a. (Corresponding author)

153.  Kuo HC*. Diagnosis, Progress, and Treatment Update of Kawasaki Disease. Int J Mol Sci. 2023 Sep 11;24(18):13948. (Single author)

154.  Guo MM, Chang LS, Chen YJ, Kuo HC.* Echocardiography and laboratory outcomes of COVID-19 in children with a history of Kawasaki disease: a preliminary observation. Front Cardiovasc Med. 2023 Oct 4;10:1127892. (Corresponding author)

155.  Huang YH, Kuo HC.* Kawasaki Disease, MIS-C and COVID-19. Children (Basel). 2023 Sep 22;10(10):1587. (editorial) (Corresponding author)